Effect of fasudil HCl, a protein kinase inhibitor, on cerebral vasospasm

Acta Neurochirurgica, Supplement

Volumn 77, Issue , 2001, Pages 201-204

  Shibuya, M ^a  

^a CHUKYO HOSPITAL   (Japan)

Author keywords

Calcium antaponist; Cerebral vasospasm; Fasudil HCl

Indexed keywords

1 (5 ISOQUINOLINESULFONYL) 2 METHYLPIPERAZINE; DRUG DERIVATIVE; ENZYME INHIBITOR; FASUDIL; PROTEIN KINASE INHIBITOR;

ANIMAL; BRAIN VASOSPASM; HUMAN; INTRAARTERIAL DRUG ADMINISTRATION; REVIEW;

1-(5-ISOQUINOLINESULFONYL)-2-METHYLPIPERAZINE; ANIMALS; ENZYME INHIBITORS; HUMANS; INJECTIONS, INTRA-ARTERIAL; PROTEIN KINASE INHIBITORS; VASOSPASM, INTRACRANIAL;

EID: 0035225346     PISSN: 00651419     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-3-7091-6232-3_42     Document Type: Article

References (2)

1. Arai M, Sasaki Y, Nozawa R. (1993) Inhibition by the protein kinase inhibitor HA 1077 of the activation of NADPH oxidase in human neutrophils. Biochem Pharmacol 46: 1487-1490
2. Asano T, Ikegaki I, Satoh S, Suzuki Y, Shibuya M, Takayasu M, Hidaka H (1990) Mechanism of action of a novel antivasospasm drug, HA1077. J Pharmacol Exp Ther 241-1033-1040